CIK 0001576280
- Large accelerated filer
Guardant Health, Inc.
Sign in to watch- Ticker
- GH
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 454139254
- Phone
- +1 855-698-8887
- Business address
- 3100 HANOVER STREET, PALO ALTO, CA, 94304
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $9,720,952
- in 8 filings, $195K under 10b5-1 plans
Net −$9,720,952. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-08 | Hidalgo Medina Manuel Director | Sale | −250 | $105.00 | $26K | 797 |
| 2025-12-08 | Hidalgo Medina Manuel Director | Option exercise · Stock Option (Right to Buy) | −1,000 | 15,029 | ||
| 2025-12-08 | Talasaz AmirAli Co-Chief Executive Officer | Other disposition | −387,946 | 82,854 | ||
| 2025-12-08 | Talasaz AmirAli Co-Chief Executive Officer | Other acquisition | +193,973 | 218,223 | ||
| 2025-12-08 | Talasaz AmirAli Co-Chief Executive Officer | Other acquisition | +193,973 | 218,223 | ||
| 2025-12-08 | Talasaz AmirAli Co-Chief Executive Officer | Sale | −15,000 | $104.21 | $1.6M | 203,223 |
| 2025-12-08 | Talasaz AmirAli Co-Chief Executive Officer | Sale | −30,760 | $105.34 | $3.2M | 172,463 |
| 2025-12-08 | Talasaz AmirAli Co-Chief Executive Officer | Sale | −4,240 | $106.00 | $449K | 168,223 |
| 2025-12-08 | Talasaz AmirAli Co-Chief Executive Officer | Sale | −15,000 | $104.21 | $1.6M | 203,223 |
| 2025-12-08 | Talasaz AmirAli Co-Chief Executive Officer | Sale | −30,760 | $105.34 | $3.2M | 172,463 |
| 2025-12-08 | Talasaz AmirAli Co-Chief Executive Officer | Sale | −4,240 | $106.00 | $449K | 168,223 |
| 2025-12-05 | Freeman Chris Chief Commercial Officer | Sale | −478 | $101.43 | $48K | 56,961 |
| 2025-12-05 | Freeman Chris Chief Commercial Officer | Sale | −744 | $102.31 | $76K | 56,217 |
| 2025-12-05 | Freeman Chris Chief Commercial Officer | Sale | −372 | $103.48 | $38K | 55,845 |
| 2025-12-05 | Freeman Chris Chief Commercial Officer | Sale | −244 | $104.10 | $25K | 55,601 |
| 2025-12-05 | Freeman Chris Chief Commercial Officer | Sale | −228 | $106.63 | $24K | 55,373 |
| 2025-12-05 | Freeman Chris Chief Commercial Officer | Sale | −4,084 | $101.40 | $414K | 51,289 |
| 2025-12-05 | Freeman Chris Chief Commercial Officer | Sale | −11,969 | $102.09 | $1.2M | 39,320 |
| 2025-12-05 | Freeman Chris Chief Commercial Officer | Sale | −3,414 | $103.25 | $353K | 35,906 |
| 2025-12-05 | Freeman Chris Chief Commercial Officer | Sale | −6,555 | $103.97 | $682K | 29,351 |
Page 33 of 42 · 827 trades